publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
synthesi
vitro
cytostat
activ
new
bdarabino
furan
oxazoloand
arabinopyrimidinon
deriv
b
r
c
seri
nucleosid
deriv
obtain
via
heteroatom
annul
amino
oxazolin
arabinos
unequivoc
proof
stereostructur
new
arabinosyl
pyrimidinon
deriv
obtain
xray
structur
analysi
newli
synthes
compound
evalu
cytostat
activ
murin
leukemia
human
tlymphocyt
molt
cem
compound
seri
protect
silyl
tricycl
fuse
pyrimidinon
show
signific
antitumor
activ
murin
leukemia
ic
mm
human
tlymphocyt
cell
molt
ic
mm
cell
line
ic
mm
none
compound
exhibit
signific
antivir
inhibitori
activ
antimetabolit
wide
use
cytostat
classifi
accord
chemic
structur
mechan
action
amongst
new
antimetabolit
pyrimidin
analogu
ie
cytarabin
enocitabin
relat
synthon
fig
part
research
program
develop
synthesi
new
seri
origin
furan
oxazoloand
arabinopyrimidinon
via
deriv
possess
parent
heteroamidin
synthon
use
prepar
variou
bioactiv
pyrimidinon
ring
annul
use
two
nucleophil
site
amidin
moieti
alreadi
develop
approach
obtain
variou
bicycl
compound
work
report
synthesi
seri
new
furan
oxazoloand
arabinopyrimidinon
deriv
molecular
biodivers
strategi
preliminari
result
cytostat
activ
murin
leukemia
human
tlymphocyt
molt
cem
readili
avail
either
unprotect
compound
scheme
silyl
compound
scheme
prepar
accord
previous
describ
procedur
use
start
materi
synthesi
bdarabino
furan
oxazoloand
arabinopyrimidinon
deriv
n
ndimethylformamid
dimethylacet
dmfdma
react
give
expect
amidin
scheme
n
n
dimethyln
alkylformamid
engag
alkyl
diketen
aceton
adduct
follow
spontan
elimin
dimethylamin
give
fuse
bdarabinofuran
oxazolin
ring
open
conduct
dilut
aqueou
ammonia
afford
surpris
arabinofuranopyrimidinedion
bear
enamin
function
structur
elucid
achiev
either
h
c
nmr
xray
crystallographi
fig
especi
h
nmr
spectrum
reveal
two
exchang
singlet
ppm
characterist
enamin
group
posit
moreov
c
nmr
spectrum
show
one
signal
around
ppm
specif
enamin
alken
bond
c
nh
xray
crystallographi
data
unambigu
show
presenc
two
hydrogen
n
wherea
csp
n
bond
found
typic
observ
c
cnh
bond
intramolecular
hydrogen
bond
n
h
n
distanc
angst
moreov
n
hydrogen
bond
molecul
x
n
h
hydrogen
bond
found
n
molecul
x
z
distanc
molecul
z
angst
common
type
pucker
sugar
ring
nucleosid
nucleotid
either
atom
c
atom
c
displac
plane
four
atom
side
atom
c
pucker
call
c
c
endo
respect
structur
pucker
c
endo
differ
observ
previous
describ
uracilbdarabinofuranosid
pucker
c
endo
make
imposs
intramolecular
hydrogen
bond
final
spatial
structur
also
confirm
oxazolin
ring
open
modifi
absolut
configur
arabinos
base
space
group
determin
crystallograph
data
absolut
configur
pure
enantiom
determin
r
respect
format
probabl
due
action
ammonia
acetyl
substitu
lead
imin
function
gave
stabl
enamin
group
alkalin
oxazolin
ring
open
hand
treatment
sodium
ethanol
afford
expect
pyrimidinedion
scheme
diethyl
ethoxymethylen
malon
deem
wellknown
biselectrophil
reagent
use
heterocycl
ring
annel
react
room
temperatur
fuse
pyrimidinon
bear
bketo
ester
moieti
obtain
probabl
due
regioselect
term
nitrogen
reactiv
previous
observ
seri
oxazolin
ring
open
conduct
ammonium
hydroxyd
give
sugar
deriv
yield
scheme
depict
scheme
bi
otertbutyldimethylsilyl
bdarabinofuran
subsequ
react
dmfdma
give
describ
react
diketen
aceton
adduct
aceton
give
previous
describ
synthesi
unprotect
amino
oxazolin
spatial
determin
establish
xray
crystallographi
confirm
structur
solid
state
fig
altern
reaction
reflux
styren
led
mixtur
isomer
angularli
linearli
annel
nitrogen
bridgehead
compound
onestep
ring
annul
synthesi
illustr
nucleophil
reactiv
nitrogen
atom
thu
endocycl
nitrogen
atom
attack
first
electrophil
carbonyl
carbon
follow
exocycl
nitrogen
attack
carboxyl
carbon
afterward
achiev
cyclis
result
unstabl
cyclic
bhydroxyketon
dehydr
give
hand
compound
obtain
dehydr
two
nitrogen
atom
attack
order
revers
separ
two
regioisom
obtain
yield
respect
structur
probe
nmr
analysi
thu
noe
effect
arabinos
proton
one
methylen
proton
fuse
cyclohexyl
moieti
observ
compound
correl
observ
two
correspond
proton
unequivoc
assign
two
differ
possibl
structur
xray
singl
crystal
analys
perform
fig
fig
structur
confirm
isomer
anticip
basi
noesi
data
regioisom
character
quasiplanar
conform
oxazolo
pyrimidin
moieti
dihedr
angl
mean
plane
pyrimidin
base
sugar
ring
respect
compound
maximum
deviat
planar
tricycl
cyclohexaoxazolopyrimidinon
moieti
found
lie
c
deviat
plane
cyclohexenyl
cycl
c
n
c
c
bond
respect
typic
observ
doubl
bond
compound
distanc
pyrimidin
ring
c
n
c
c
regioisom
desilyl
tetrabutyl
ammonium
fluorid
tbaf
thf
give
respect
follow
oxazolin
ring
open
etona
arabinos
deriv
eventu
obtain
rel
poor
yield
respect
newli
synthes
compound
evalu
vitro
inhibitori
effect
prolifer
murin
leukemia
cell
human
tlymphocyt
cell
molt
tabl
compound
theoret
calcul
lipophil
clog
p
perform
use
marvinsketch
program
appear
tabl
compound
show
cytotox
activ
ic
mm
belong
silyl
seri
nucleosid
deriv
compound
found
possess
interest
activ
leukemia
human
tlymphocyt
cell
ic
rang
mm
mm
respect
fuse
tricycl
pyrimidinon
found
potent
compound
wherea
ring
open
lead
compound
provid
lower
activ
must
note
ring
open
process
heterocycl
ring
structur
rather
differ
precursor
compound
sinc
enamin
group
replac
acetyl
group
group
could
consid
bioisoster
may
involv
biolog
bind
site
compound
hand
lack
reactiv
function
pyrimidin
moieti
found
less
activ
preliminari
result
could
relat
lipophil
behaviour
test
compound
highlight
calcul
log
p
paramet
tabl
expect
silyl
compound
lipophil
one
lipophil
charact
could
explain
first
part
better
permeabl
lead
better
cell
penetr
vitro
hand
compar
clog
p
differ
found
correspond
valu
calcul
respect
desilyl
pyrimidinon
show
lower
activ
ic
rang
mm
three
cell
line
tetracyl
fuse
isomer
pyrimidinon
also
exhibit
moder
antitumor
activ
slightli
better
ic
ic
mm
ic
mm
molt
ic
mm
final
moder
result
obtain
compound
ic
mm
rather
difficult
discuss
sinc
compound
appear
earli
stage
synthesi
therefor
exhibit
quit
differ
chemic
structur
compar
interest
compound
nevertheless
compar
desilyl
analog
show
activ
stress
import
role
tertbutyldimethylsilyl
group
subtyp
b
mdck
cell
cultur
specif
antivir
effect
ie
minim
antivir
effect
concentr
fivefold
lower
minim
cytotox
concentr
note
compound
virus
evalu
data
shown
nevertheless
fuse
pyrimidinon
show
appreci
antivir
activ
vaccinia
viru
effect
concentr
ec
mm
summari
report
synthesi
new
arabinosyl
pyrimidinon
deriv
togeth
cytostat
activ
molt
cem
tumor
cell
line
stereostructur
unambigu
confirm
xray
structur
analysi
seri
lipophil
silyl
deriv
found
biolog
activ
use
lead
compound
search
activ
potent
nucleosid
analogu
appli
cancer
chemotherapi
commerci
reagent
use
receiv
without
addit
purif
melt
point
determin
smluxpol
leitz
hotstag
microscop
uncorrect
ir
spectra
record
bruker
spectrophotomet
nmr
spectra
obtain
bruker
avanc
spectromet
mhz
h
mhz
c
deuter
dimethylsulfoxid
dmsod
chloroform
cdcl
use
solvent
dmso
h
dmsod
c
chcl
h
cdcl
c
respect
employ
intern
standard
silica
gel
mesh
use
column
chromatographi
homogen
newli
synthes
compound
routin
check
tlc
silica
gel
plate
polygram
sil
guv
visual
irradi
uv
lamp
element
analys
conduct
cnr
vernaison
franc
structur
compound
establish
xray
crystallographi
fig
data
correct
lorentz
polar
effect
empir
absorpt
correct
structur
solv
direct
method
shelx
refin
use
shelx
suit
program
white
singl
crystal
solut
g
mmol
methanol
ml
rt
rapidili
ad
ammonium
hydroxyd
soln
ml
stir
h
rt
solut
concentr
reduc
pressur
residu
purifi
silica
gel
use
chloroformmethanol
eluant
give
g
mp
solut
compound
g
mol
ethanol
ml
quickli
ad
sodium
ethanol
g
mol
room
temperatur
yellow
solut
stir
h
rt
concentr
reduc
pressur
residu
pour
water
ml
acidifi
ph
aqueou
hcl
water
remov
vacuum
absolut
alcohol
ml
ad
residu
filtrat
nacl
remov
filtrat
concentr
result
solid
recrystal
methanol
solut
g
mol
minimum
amount
absolut
ethanol
deem
g
mol
ad
stir
room
temperatur
stir
continu
h
solut
concentr
reduc
pressur
result
residu
appli
column
silica
gel
elut
chloroformmethanol
give
g
mp
c
ir
n
cm
stir
solut
g
mmol
aceton
ml
c
diketen
aceton
adduct
g
mmol
ad
dropwis
stir
h
solut
concentr
reduc
pressur
result
visquou
residu
appli
silica
gel
chloroformmethanol
eluant
titl
compound
isol
fluoresc
solid
recrystal
aqueou
ethanol
yield
pure
g
mp
c
solut
g
mol
thf
ml
rt
rapidili
ad
ammonium
hydroxyd
soln
ml
stir
h
rt
solut
concentr
reduc
pressur
result
yellow
residu
purifi
silica
gel
use
chloroformmethanol
eluant
give
g
mp
c
stir
solut
g
mmol
ethanol
ml
ad
sodium
ethyl
mol
room
temperatur
mixtur
heat
c
stir
h
room
temperatur
concentr
reduc
pressur
residu
taken
water
ml
acidifi
aqueou
hcl
ph
concentr
dryness
absolut
ethanol
ml
ad
mixtur
filter
filtrat
evapor
crude
product
submit
column
chromatographi
elut
chloroformmethanol
give
pure
stir
solut
g
mol
ethanol
ml
ad
sodium
ethyl
mol
room
temperatur
mixtur
heat
c
stir
h
room
temperatur
concentr
reduc
pressur
residu
taken
water
ml
acidifi
aqueou
hcl
ph
concentr
dryness
absolut
ethanol
ml
ad
mixtur
filter
filtrat
evapor
crude
product
submit
column
chromatographi
elut
chloroformmethanol
give
pure
j
hz
oh
exchang
j
hz
oh
exchang
j
hz
oh
exchang
j
hz
murin
leukemia
human
tlymphocyt
molt
cem
cell
suspend
cellsml
cultur
medium
amount
ml
cell
suspens
ad
ml
microtit
plate
well
contain
ml
appropri
dilut
test
compound
day
day
molt
cem
incub
c
cell
number
determin
use
coulter
counter
cytostat
concentr
ic
defin
compound
concentr
requir
inhibit
cell
prolifer
antivir
activ
compound
determin
describ
assay
base
inhibit
virusinduc
cytopath
hel
herp
simplex
viru
type
ko
g
vaccinia
viru
vesicular
stomat
viru
vero
sindbi
coxsacki
punta
toro
viru
hela
vesicular
stomat
viru
coxsacki
viru
respiratori
syncyti
viru
mdck
influenza
influenza
b
cell
cultur
confluent
cell
cultur
microtit
plate
inocul
ccid
viru
ccid
viru
dose
infect
cell
cultur
h
viru
adsorpt
period
residu
viru
remov
cell
cultur
incub
presenc
vari
concentr
mm
test
compound
viral
cytopath
record
soon
reach
complet
control
virusinfect
cell
cultur
treat
test
compound
